| Id |
Subject |
Object |
Predicate |
Lexical cue |
| TextSentencer_T1 |
0-50 |
Sentence |
denotes |
COVID-19 (Novel Coronavirus 2019) - recent trends. |
| TextSentencer_T2 |
51-255 |
Sentence |
denotes |
The World Health Organization (WHO) has issued a warning that, although the 2019 novel coronavirus (COVID-19) from Wuhan City (China), is not pandemic, it should be contained to prevent the global spread. |
| TextSentencer_T3 |
256-306 |
Sentence |
denotes |
The COVID-19 virus was known earlier as 2019-nCoV. |
| TextSentencer_T4 |
307-393 |
Sentence |
denotes |
As of 12 February 2020, WHO reported 45,171 cases and 1115 deaths related to COVID-19. |
| TextSentencer_T5 |
394-538 |
Sentence |
denotes |
COVID-19 is similar to Severe Acute Respiratory Syndrome coronavirus (SARS-CoV) virus in its pathogenicity, clinical spectrum, and epidemiology. |
| TextSentencer_T6 |
539-744 |
Sentence |
denotes |
Comparison of the genome sequences of COVID-19, SARS-CoV, and Middle East Respiratory Syndrome coronavirus (MERS-CoV) showed that COVID-19 has a better sequence identity with SARS-CoV compared to MERS CoV. |
| TextSentencer_T7 |
745-908 |
Sentence |
denotes |
However, the amino acid sequence of COVID-19 differs from other coronaviruses specifically in the regions of 1ab polyprotein and surface glycoprotein or S-protein. |
| TextSentencer_T8 |
909-1034 |
Sentence |
denotes |
Although several animals have been speculated to be a reservoir for COVID-19, no animal reservoir has been already confirmed. |
| TextSentencer_T9 |
1035-1106 |
Sentence |
denotes |
COVID-19 causes COVID-19 disease that has similar symptoms as SARS-CoV. |
| TextSentencer_T10 |
1107-1243 |
Sentence |
denotes |
Studies suggest that the human receptor for COVID-19 may be angiotensin-converting enzyme 2 (ACE2) receptor similar to that of SARS-CoV. |
| TextSentencer_T11 |
1244-1343 |
Sentence |
denotes |
The nucleocapsid (N) protein of COVID-19 has nearly 90% amino acid sequence identity with SARS-CoV. |
| TextSentencer_T12 |
1344-1446 |
Sentence |
denotes |
The N protein antibodies of SARS-CoV may cross react with COVID-19 but may not provide cross-immunity. |
| TextSentencer_T13 |
1447-1606 |
Sentence |
denotes |
In a similar fashion to SARS-CoV, the N protein of COVID-19 may play an important role in suppressing the RNA interference (RNAi) to overcome the host defense. |
| TextSentencer_T14 |
1607-1680 |
Sentence |
denotes |
This mini-review aims at investigating the most recent trend of COVID-19. |
